IO Biotech

IOBT

Market cap $3.45M

Delisted

IOBT was delisted on the 6th of April, 2026.

#	Name	Holding	Trade Value	Shares Change	Change in Stake
1	NHAS 1 Novo Holdings A/S Hellerup, Denmark	$17.4M	–	–	–
2	VC 2 Vivo Capital Palo Alto, California	$16M	–	–	–
3	RCM 3 RA Capital Management Boston, Massachusetts	$9.85M	–	–	–
4	ACA 4 Avoro Capital Advisors New York	$9.58M	–	–	–
5	PHS 5 PFM Health Sciences San Francisco, California	$6.65M	–	–	–
6	6 Capital World Investors Los Angeles, California	$6.55M	–	–	–
7	SB 7 Samsara BioCapital Palo Alto, California	$5.94M	–	–	–
8	SCM 8 Soleus Capital Management Greenwich, Connecticut	$3.56M	–	–	–
9	9 Millennium Management New York	$385K	-$34.6K	-5,235	-7%
10	10 Vanguard Group Malvern, Pennsylvania	$330K	-$945K	-142,966	-70%
11	11 Susquehanna International Group Bala Cynwyd, Pennsylvania	$141K	+$176K	+26,676	New
12	12 Norges Bank Oslo, Norway	$133K	–	–	–
13	13 Morgan Stanley New York	$87K	+$49.8K	+7,529	+84%
14	14 Jane Street New York	$76K	+$94.4K	+14,280	New
15	15 Geode Capital Management Boston, Massachusetts	$67K	+$10.3K	+1,557	+14%
16	E 16 Ergoteles New York	$59K	+$73.5K	+11,126	New
17	17 Bank of America Charlotte, North Carolina	$53K	–	–	–
18	18 Stifel Financial St. Louis, Missouri	$53K	–	–	–
19	19 Citigroup New York	$1K	+$1.08K	+164	New
20	CCM 20 CAAS Capital Management New York	–	-$323K	-50,479	Closed
21	21 Squarepoint New York	–	-$98K	-14,966	Closed
22	22 Citadel Advisors Miami, Florida	–	-$86K	-13,060	Closed
23	VF 23 Virtu Financial New York	–	-$83K	-12,665	Closed
24	TRCT 24 Tower Research Capital (TRC) New York	–	-$10K	-1,572	Closed